Page last updated: 2024-11-02

pentobarbital and Hypertension, Malignant

pentobarbital has been researched along with Hypertension, Malignant in 2 studies

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.

Hypertension, Malignant: A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
OLMER, J1
CARCASSONNE, Y1
Miura, Y1

Other Studies

2 other studies available for pentobarbital and Hypertension, Malignant

ArticleYear
[MALIGNANT ARTERIAL HYPERTENSION: PROLONGED EFFECTS OF SLEEP THERAPY].
    Marseille medical, 1964, Volume: 101

    Topics: Chlorpromazine; Hypertension; Hypertension, Malignant; Pentobarbital; Promethazine; Sleep

1964
Improved method for measurement of renin activity in human plasma.
    The Tohoku journal of experimental medicine, 1969, Volume: 98, Issue:2

    Topics: Angiotensin II; Animals; Biological Assay; Blood Pressure; Chromatography; Edetic Acid; Female; Huma

1969